SCHEMBL8727410

SCHEMBL8727410

COC(=O)c1ccc(OC[C]=O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.68
RAB9A P51151 4/20 0.60
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
SMN1; SMN2 Q16637 4/20 0.55
NPC1 O15118 3/20 0.55
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
LMNA P02545 3/20 0.51
GAA P10253 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
TSHR P16473 1/20 0.51
ALDH1A1 P00352 1/20 0.50
CA12 O43570 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
POLB P06746 1/20 0.49
BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL254800 0.84 MAPT (0.66) MAPTRAB9ACA1CA2SMN1; SMN2
SCHEMBL1249230 0.84 MAPT (0.66) MAPTRAB9ACA1CA2SMN1; SMN2
SCHEMBL29723230 0.83 MAPT (0.64) MAPTRAB9ACA1CA2SMN1; SMN2
SCHEMBL1503512 0.83 MAPT (0.64) MAPTRAB9ACA1CA2SMN1; SMN2
SCHEMBL9353433 0.81 L3MBTL1 (0.63) MAPTRAB9ASMN1; SMN2LMNAGAA
SCHEMBL11082868 0.81 GABRA1 (0.46) MAPTRAB9ACA1CA2SMN1; SMN2
SCHEMBL1951546 0.81 MAPT (1.00) MAPTRAB9ACA1CA2SMN1; SMN2
SCHEMBL8729249 0.80 MRGPRX4 (0.53) MAPTRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL8011558 0.79 PKM (0.58) RAB9ACA1CA2SMN1; SMN2NPC1
SCHEMBL10295156 0.79 MAPT (0.75) MAPTRAB9ACA1CA2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998043649-A2 AGE PRODUCTION INHIBITORY COMPOSITION COMPRISING A MAILLARD REACTION INHIBITOR AND VITAMIN B¿6? OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-10-08 WO disclosed
US-5422360-A Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-06-06 US disclosed
EP-0531812-A1 Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 EP disclosed